| Yuri Yakubov, CRNA | |
|
100 Woods Rd, Valhalla, NY 10595-1530 | |
| (914) 493-7000 | |
| Not Available |
| Full Name | Yuri Yakubov |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 7 Years |
| Location | 100 Woods Rd, Valhalla, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770099681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 652056 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Long Island Jewish Medical Center | New hyde park, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Anesthesiology, Pc | 1153602453 | 779 |
News Archive
Ahead of a vote on repeal in the GOP-led House this week, strong opposition to the law stands at 30 percent, close to the lowest level registered in AP-GfK surveys dating to September 2009. ... The law expands coverage to more than 30 million uninsured, and would require, for the first time, that most people in the United States carry health insurance.
Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.
› Verified 7 days ago
| Entity Name | Long Island Anesthesia Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952387276 PECOS PAC ID: 7113825381 Enrollment ID: O20040106000103 |
News Archive
Ahead of a vote on repeal in the GOP-led House this week, strong opposition to the law stands at 30 percent, close to the lowest level registered in AP-GfK surveys dating to September 2009. ... The law expands coverage to more than 30 million uninsured, and would require, for the first time, that most people in the United States carry health insurance.
Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.
› Verified 7 days ago
| Entity Name | North American Partners In Anesthesia Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649264706 PECOS PAC ID: 7719885771 Enrollment ID: O20040108000176 |
News Archive
Ahead of a vote on repeal in the GOP-led House this week, strong opposition to the law stands at 30 percent, close to the lowest level registered in AP-GfK surveys dating to September 2009. ... The law expands coverage to more than 30 million uninsured, and would require, for the first time, that most people in the United States carry health insurance.
Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.
› Verified 7 days ago
| Entity Name | Westchester Medical Center Advanced Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912131392 PECOS PAC ID: 3173660776 Enrollment ID: O20091031000042 |
News Archive
Ahead of a vote on repeal in the GOP-led House this week, strong opposition to the law stands at 30 percent, close to the lowest level registered in AP-GfK surveys dating to September 2009. ... The law expands coverage to more than 30 million uninsured, and would require, for the first time, that most people in the United States carry health insurance.
Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.
› Verified 7 days ago
| Entity Name | North Shore - Lij Anesthesiology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417401266 PECOS PAC ID: 1153602453 Enrollment ID: O20161228001498 |
News Archive
Ahead of a vote on repeal in the GOP-led House this week, strong opposition to the law stands at 30 percent, close to the lowest level registered in AP-GfK surveys dating to September 2009. ... The law expands coverage to more than 30 million uninsured, and would require, for the first time, that most people in the United States carry health insurance.
Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.
› Verified 7 days ago
| Entity Name | Quality Medical Management Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114502606 PECOS PAC ID: 5799193074 Enrollment ID: O20210427000857 |
News Archive
Ahead of a vote on repeal in the GOP-led House this week, strong opposition to the law stands at 30 percent, close to the lowest level registered in AP-GfK surveys dating to September 2009. ... The law expands coverage to more than 30 million uninsured, and would require, for the first time, that most people in the United States carry health insurance.
Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yuri Yakubov, CRNA 230 174th St Apt 1101, Sunny Isles Beach, FL 33160-3330 Ph: (347) 634-6050 | Yuri Yakubov, CRNA 100 Woods Rd, Valhalla, NY 10595-1530 Ph: (914) 493-7000 |
News Archive
Ahead of a vote on repeal in the GOP-led House this week, strong opposition to the law stands at 30 percent, close to the lowest level registered in AP-GfK surveys dating to September 2009. ... The law expands coverage to more than 30 million uninsured, and would require, for the first time, that most people in the United States carry health insurance.
Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.
› Verified 7 days ago
Mrs. Deirdre Mary Mullen, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 95 Grasslands Rd, Valhalla, NY 10595 Phone: 914-493-7693 | |
Maria I Cashin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 Fax: 914-493-7927 | |
Mr. Adeel Cyril, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 Fax: 914-493-7927 | |
Mrs. Jenine C Salisbury, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 Fax: 914-493-7927 | |
Ms. Adefunke F Omolade, RN, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 Fax: 914-493-8439 | |
Julie Setaro, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-2844 Fax: 914-493-2948 | |
Keneil Edmond, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 Fax: 914-493-7927 |